Literature DB >> 6367690

Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.

P E Stokes, P M Stoll, S H Koslow, J W Maas, J M Davis, A C Swann, E Robins.   

Abstract

Pretreatment measures of hypothalamic-pituitary-adrenocortical (HYPAC) function in depressed, manic, and healthy normal subjects showed that nonsuppression on the dexamethasone suppression test (DST) had less positive predictive value for major diagnostic category and was more frequent in normals (8/77) than recently reported, although it was yet more frequent in depressed patients (35/111). Nonsuppression was common in manics (8/16), was similar in unipolar and bipolar depressed patients (35% and 27%, respectively), and did not segregate with melancholic, endogenous, or psychotic depression subtypes. Patterns of post-DST plasma cortisol concentration other than simple escape or nonescape from suppression were common. Nonsuppression of 9 AM plasma cortisol levels on the DST had as good or better diagnostic specificity as nonsuppression of any of three post-DST samples. Nonsuppression was not completely synonymous with HYPAC hypersecretion. Means of pre-DST HYPAC measures (morning plasma cortisol, urine free cortisol, and CSF cortisol levels) were elevated in depressed patients compared with normals. There were significant differences in HYPAC measures of depressed patients studied at different centers. Age correlated positively and body weight negatively with plasma cortisol level.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367690     DOI: 10.1001/archpsyc.1984.01790140047006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  20 in total

Review 1.  Internalizing disorders in early childhood: a review of depressive and anxiety disorders.

Authors:  Mini Tandon; Emma Cardeli; Joan Luby
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-07

2.  Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: a negative study.

Authors:  M Ansseau; R von Frenckell; C Simon; J Sulon; E Demey-Ponsart; G Franck
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

4.  Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach.

Authors:  R J Branconnier; G F Oxenkrug; I McIntyre; N Pomara; N E Harto; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

6.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

7.  Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.

Authors:  M Maes; B Minner; E Suy; C Vandervorst; J Raus
Journal:  J Neural Transm Gen Sect       Date:  1991

8.  The relationships between the availability ofL-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients.

Authors:  M Maes; B Minner; E Suy
Journal:  Amino Acids       Date:  1991-02       Impact factor: 3.520

9.  Sleep during mania in manic-depressive males.

Authors:  P Linkowski; M Kerkhofs; C Rielaert; J Mendlewicz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

10.  Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.

Authors:  Cornelius Schüle; Thomas Baghai; Peter Zwanzger; Robin Ella; Daniela Eser; Frank Padberg; Hans-Jürgen Möller; Rainer Rupprecht
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.